SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?


To: Bonefish who wrote (1319213)9/12/2021 1:58:03 PM
From: Wharf Rat  Read Replies (2) | Respond to of 1584064
 
Rat got Moderna. I'll show up for a booster when I get a call from the health center.

CDC data indicates Moderna vaccine more effective against delta variant of COVID-19 than Pfizer, J&J
CORONAVIRUS
by: Aubree Bailey

Posted: Sep 10, 2021 / 01:44 PM CDT / Updated: Sep 10, 2021 / 01:44 PM CDT



BIRMINGHAM, Ala. ( WIAT) — Data released Friday by the Center for Disease Control indicates that the Moderna vaccine is actually more effective against the delta variant compared to the Pfizer and Johnson & Johnson vaccines.

Lack of ICU beds due to COVID-19 forces Cullman man who suffered heart event to travel 200 miles for care
In a weekly report on morbidity and mortality in the US, data shows that the Moderna vaccine effectiveness has a rate of 95% when it comes to hospitalizations due to the delta variant, while Pfizer sits at 80% and Johnson & Johnson at 60%.

The effectiveness rate for Moderna against urgent care and emergency room visits sits at 92%. Pfizer and Johnson & Johnson have rates of 77% and 65%, respectively.

“These findings reaffirm the high protection of COVID-19 vaccines against moderate and severe COVID-19 resulting in Emergency Department, Urgent Care, and hospital visits and underscore the importance of full COVID-19 vaccination and continued benefits of COVID-19 vaccination during Delta variant predominance,” the report said.

Moderna also recently announced it is working on hybrid COVID-19/Flu vaccine.

cbs42.com